Intellipharmaceutics to Present at the LD Micro Main Event
November 24, 2015 12:00 ET
|
Intellipharmaceutics International Inc.
TORONTO, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics to Present at The MicroCap Conference
October 27, 2015 06:15 ET
|
Intellipharmaceutics International Inc.
TORONTO, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics to Present at Dawson James Securities Growth Stock Conference
October 09, 2015 07:00 ET
|
Intellipharmaceutics International Inc.
TORONTO, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Announces Third Quarter 2015 Results
October 09, 2015 07:00 ET
|
Intellipharmaceutics International Inc.
TORONTO, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Updates Status of Tentative Approvals of Generic Focalin XR(R)
August 05, 2015 08:15 ET
|
Intellipharmaceutics International Inc.
TORONTO, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Announces Second Quarter 2015 Results
July 13, 2015 07:30 ET
|
Intellipharmaceutics International Inc.
TORONTO, July 13, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Updates Status of Tentative Approvals of Generic Focalin XR(R)
July 08, 2015 18:20 ET
|
Intellipharmaceutics International Inc.
TORONTO, July 8, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Updates Status of Tentative Approvals of Generic Focalin XR(R)
June 18, 2015 17:30 ET
|
Intellipharmaceutics International Inc.
TORONTO, June 18, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
FDA Grants Fast Track Designation for Intellipharmaceutics Rexista(TM) Oxycodone XR Incorporating PODRAS(TM) Technology
May 26, 2015 08:00 ET
|
Intellipharmaceutics International Inc.
TORONTO, May 26, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Announces Agreement to Acquire Real Property that Houses its Manufacturing, R&D and Office Facilities in Toronto, Ontario and Status of 5mg Strength of its Generic Focalin XR(R)
May 25, 2015 20:50 ET
|
Intellipharmaceutics International Inc.
TORONTO, May 25, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...